why do people gain weight after semaglutide If I Stop Will I Weight: What to Expect Woman shares how she kept

Despite these concerns, there is currently no evidence to suggest that BPC57 has caused tumors to grow more quickly in humans or animals, and most compounds that are carcinogenic will show a signature of cancer in animal studies 6m30s

In the study, adults taking Wegovy lost an average of 35 pounds, or 14.9% of their body weight

Researchers reviewing GLP-1, GIP and glucagon pathway compounds often pay close attention to gastrointestinal tolerability because it can affect study continuation, dose escalation design and participant experience in controlled clinical settings

GLP-1 agonists slow stomach emptying by 30-50%, which means foods that expand in the stomachincluding high-fiber oatmealmay increase nausea or early satiety in some patients

Even in settings where clinical response to biologics is preserved, the presence of obesity provides a strong rationale for adjunctive metabolic interventions